We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Black Raspberry Diet Partially Restores Normal Gene Expression

By LabMedica International staff writers
Posted on 10 Sep 2008
Cancer researchers have found that a diet enriched with freeze-dried black raspberries partially protected rats from development of artificially induced esophageal cancer.

Black raspberries contain vitamins, minerals, phenols, and phytosterols, many of which individually are known to prevent cancer in animals. More...
Freeze-drying the berries concentrates these elements about 10 times and allows more precise dietary control.

Investigators from Ohio State University College of Medicine (Columbus, OH, USA) fed rats either a normal diet or a diet containing 5% black-raspberry powder. During the third week, half the animals in each diet group were injected three times with a chemical carcinogen, N-nitrosomethylbenzylamine. The animals continued consuming the diets during the week of carcinogen treatment. After the third week, the investigators analyzed the expression of 41,000 genes in esophageal tissue removed from the animals.

Results published in the August 1, 2008, online issue of the journal Cancer Research revealed that the carcinogenic treatment caused dysregulation of 2,261 genes. However, the raspberry diet restored 462 of these genes to normal expression. These results complement previous results that 1,323 genes were protected when animals were fed phenylethyl isothiocyanate (PEITC).

After comparing the data, it was found that a group of 53 genes was restored by both diets. These 53 common genes included genes involved in oxidative damage, oncogenes, and tumor-suppressor genes that regulate apoptosis, cell cycling, and angiogenesis. Since both PEITC and black raspberries maintained near-normal levels of expression of these 53 genes, their dysregulation during the early phase of induced esophageal cancer may be especially important in the genesis of the disease.

"We have clearly shown that berries, which contain a variety of anticancer compounds, have a genome-wide effect on the expression of genes involved in cancer development,” said first author Dr. Gary D. Stoner, professor of pathology, human nutrition, and medicine at the Ohio State University College of Medicine. "This suggests to us that a mixture of preventative agents, which berries provide, may more effectively prevent cancer than a single agent that targets only one or a few genes.”

"What is emerging from studies in cancer chemoprevention is that using single compounds alone is not enough,” said Dr. Stoner. "And berries are not enough. We never get 100% tumor inhibition with berries. So we need to think about another food that we can add to them that will boost the chemopreventive activities of berries alone.”

Related Links:
Ohio State University College of Medicine




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.